お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙:旅行用ワクチン市場:世界の業界動向、シェア、規模、成長、機会、予測(2021~2026年)
市場調査レポート
商品コード
999836

旅行用ワクチン市場:世界の業界動向、シェア、規模、成長、機会、予測(2021~2026年)

Travel Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

出版日: | 発行: IMARC Services Private Limited | ページ情報: 英文 107 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.22円
旅行用ワクチン市場:世界の業界動向、シェア、規模、成長、機会、予測(2021~2026年)
出版日: 2021年04月12日
発行: IMARC Services Private Limited
ページ情報: 英文 107 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の旅行用ワクチンの市場規模は2020年に29億4千万米ドルに達しました。旅行予防接種とも呼ばれる旅行用ワクチンは、旅行者が世界中の特定の地域を訪れる前に入手できるワクチンであり、深刻な病気から身を守るのに役立ちます。旅行用ワクチンは、微生物またはそれが防御する病気の微生物の一部に体を暴露することによって作用します。体はワクチン接種に反応して、将来病気にさらされる状況から体を保護する抗体を作ります。

世界中の国際観光客の到着数は、2012年の10億人から2018年には約14億人に増加しました。これらの旅行者のかなりの数が、先進国から風土病のある地域に旅行しています。より多くの人々が風土病のある国に旅行するにつれて、ワクチンの需要は増加し続けるでしょう。さらに、世界中の規制当局は、旅行者が病気になりやすい地域に旅行する前に予防接種を受けることも義務付けています。その結果、旅行用ワクチンは今や国際的な旅行者リストの必須要件となっています。たとえば、サウジアラビア王国の保健省は、黄熱病、髄膜炎菌性髄膜炎、ポリオなどの病気のリスクがある国または地域からメッカ巡礼とウムラに到着するすべての旅行者に、有効な予防接種証明書を提示することを義務付けています。旅行用ワクチンの需要を促進する要因としては他にも、意識レベルの向上、技術の進歩、生命を脅かす感染症の発生率の上昇などがあります。世界の旅行用ワクチン市場は、2021年から2026年にかけて8.10%のCAGRで拡大すると予測されています。

当レポートでは、旅行用ワクチン市場について調査し、市場の概要とともに、組成別、疾患別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 序文

第2章 範囲と調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

第5章 世界の旅行用ワクチン市場

  • 市場概要
  • 市場パフォーマンス
  • COVID-19の影響
  • 組成別の市場セグメンテーション
  • 疾患別の市場セグメンテーション
  • 地域別の市場セグメンテーション

第6章 市場セグメンテーション、組成別

  • モノワクチン
  • 混合ワクチン

第7章 市場セグメンテーション、疾患別

  • A型肝炎
  • DPT
  • 黄熱病
  • 腸チフス
  • B型肝炎
  • はしかとおたふく風邪
  • 狂犬病
  • 髄膜炎菌
  • 水痘
  • 日本脳炎
  • その他

第8章 市場セグメンテーション、地域別

  • 北米
  • 欧州
  • アジア太平洋
  • 中東とアフリカ
  • ラテンアメリカ

第9章 世界の旅行用ワクチン業界: SWOT分析

  • 概要
  • 強み
  • 弱点
  • 市場機会
  • 脅威

第10章 世界の旅行用ワクチン業界:バリューチェーン分析

  • 探索段階
  • 前臨床および臨床開発
  • 規制当局の承認
  • 製造
  • マーケティングと流通

第11章 世界の旅行用ワクチン業界:ポーターズファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合
  • 新規参入業者の脅威
  • 代替品の脅威

第12章 世界の旅行用ワクチン業界:価格分析

第13章 旅行用ワクチンの製造プロセス

  • 製品の概要
  • 原材料の要件
  • 製造プロセス
  • 主な成功とリスク要因

第14章 競合情勢

  • 市場構造
  • キープレーヤー
  • キープレーヤーのプロファイル
    • GlaxoSmithKline Pharmaceuticals Limited
    • Sanofi Pasteur
    • Merck & Co., Inc.
    • Novartis AG
    • Pfizer Inc.
    • ALK-Abello A/S
    • Bavarian Nordic A/S
    • Crucell (Subsidiary of Johnson & Johnson)
    • CSL Limited
    • AstraZeneca PLC
    • Altimmune, Inc.
    • Abbott Laboratories
    • Hoffmann-La Roche, Inc.
図表

List of Figures

  • Figure 1: Global: Travel Vaccines Market: Major Drivers and Challenges
  • Figure 2: Global: Travel Vaccines Market: Sales Value (in Billion US$), 2015-2020
  • Figure 3: Global: Travel Vaccines Market: Breakup by Composition (in %), 2020
  • Figure 4: Global: Travel Vaccines Market: Breakup by Disease (in %), 2020
  • Figure 5: Global: Travel Vaccines Market: Breakup by Region (in %), 2020
  • Figure 6: Global: Travel Vaccines Market Forecast: Sales Value (in Billion US$), 2021-2026
  • Figure 7: Global: Travel Vaccines Industry: SWOT Analysis
  • Figure 8: Global: Travel Vaccines Industry: Value Chain Analysis
  • Figure 9: Global: Travel Vaccines Industry: Porter's Five Forces Analysis
  • Figure 10: Global: Travel Vaccines (Mono Vaccines) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 11: Global: Travel Vaccines (Mono Vaccines) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 12: Global: Travel Vaccines (Combination Vaccines) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 13: Global: Travel Vaccines (Combination Vaccines) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 14: Global: Travel Vaccines (Hepatitis A) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 15: Global: Travel Vaccines (Hepatitis A) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 16: Global: Travel Vaccines (DPT) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 17: Global: Travel Vaccines (DPT) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 18: Global: Travel Vaccines (Yellow Fever) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 19: Global: Travel Vaccines (Yellow Fever) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 20: Global: Travel Vaccines (Typhoid) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 21: Global: Travel Vaccines (Typhoid) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 22: Global: Travel Vaccines (Hepatitis B) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 23: Global: Travel Vaccines (Hepatitis B) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 24: Global: Travel Vaccines (Measles and Mumps) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 25: Global: Travel Vaccines (Measles and Mumps) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 26: Global: Travel Vaccines (Rabies) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 27: Global: Travel Vaccines (Rabies) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 28: Global: Travel Vaccines (Meningococcal) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 29: Global: Travel Vaccines (Meningococcal) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 30: Global: Travel Vaccines (Varicella) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 31: Global: Travel Vaccines (Varicella) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 32: Global: Travel Vaccines (Japanese Encephalitis) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 33: Global: Travel Vaccines (Japanese Encephalitis) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 34: Global: Travel Vaccines (Others) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 35: Global: Travel Vaccines (Others) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 36: North America: Travel Vaccines Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 37: North America: Travel Vaccines Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 38: Europe: Travel Vaccines Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 39: Europe: Travel Vaccines Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 40: Asia Pacific: Travel Vaccines Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 41: Asia Pacific: Travel Vaccines Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 42: Middle East and Africa: Travel Vaccines Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 43: Middle East and Africa: Travel Vaccines Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 44: Latin America: Travel Vaccines Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 45: Latin America: Travel Vaccines Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 46: Travel Vaccines Manufacturing: Process Flow

List of Tables

  • Table 1: Global: Travel Vaccines Market: Key Industry Highlights, 2020 and 2026
  • Table 2: Global: Travel Vaccines Market Forecast: Breakup by Composition (in Million US$), 2021-2026
  • Table 3: Global: Travel Vaccines Market Forecast: Breakup by Disease (in Million US$), 2021-2026
  • Table 4: Global: Travel Vaccines Market Forecast: Breakup by Region (in Million US$), 2021-2026
  • Table 5: Travel Vaccines: Raw Material Requirements
  • Table 6: Global: Travel Vaccines Market Structure
  • Table 7: Global: Travel Vaccines Market: Key Players
目次
Product Code: SR1020B222_Report

The global travel vaccines market reached a value of US$ 2.94 Billion in 2020. Travel vaccines, also known as travel immunizations, are vaccines travelers can get before they visit certain regions across the globe which help protect them from serious diseases. Travel vaccines work by exposing the body to a microorganism or parts of the microorganism of the disease it will protect against. The body responds to the vaccination by making antibodies that will protect it against a situation where there is an exposure to the disease in the future.

The number of international tourist arrivals worldwide increased from 1.0 Billion in 2012 to nearly 1.4 Billion in 2018. A significant number of these travelers journey from developed countries to regions with endemic diseases. As more people travel to countries with endemic diseases, the demand for vaccines will continue to increase. Moreover, regulatory authorities across the globe have also mandated that travelers should be vaccinated before traveling to disease-prone regions. As a result, travel vaccines have now become an essential requirement in an international travelers list. For instance, the Ministry of Health in the Kingdom of Saudi Arabia requires that all travelers arriving for Hajj and Umrah from countries or areas at risk of diseases such as yellow fever, Meningococcal meningitis and Poliomyelitis must present a valid vaccination certificate. Other factors driving the demand for travel vaccines include increasing awareness levels, technological advancements and increasing incidence of life-threatening infectious diseases. Looking forward, IMARC Group expects the global travel vaccines market to grow at a CAGR of 8.10% during 2021-2026.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each sub-segment of the global travel vaccines market report, along with forecasts for growth at the global, regional and country-level from 2021-2026. Our report has categorized the market based on region, composition, and disease.

Breakup by Composition:

  • Mono Vaccines
  • Combination Vaccines
  • Combination vaccines currently account for the majority of the market share as they are given to travelers in order to protect against multiple diseases.

Breakup by Disease:

  • Hepatitis A
  • DPT
  • Yellow Fever
  • Typhoid
  • Hepatitis B
  • Measles and Mumps
  • Rabies
  • Meningococcal
  • Varicella
  • Japanese Encephalitis
  • Others
  • Amongst these, hepatitis A represents the largest disease, dominating the market. It is a viral disease that can be transmitted through direct contact with an infectious person or the consumption of contaminated food and water.

Regional Insights:

  • Asia Pacific
  • North America
  • Europe
  • Middle East and Africa
  • Latin America
  • On the geographical front, North America enjoys the leading position in the market. A large number of companies in the region are introducing a superior range of travel vaccines, including a vaccine against varicella.

Competitive Landscape:

The market is concentrated in nature with the presence of a handful of manufacturers who compete in terms of prices and quality. Some of the leading players operating in the market are:

  • GlaxoSmithKline Pharmaceuticals Limited
  • Sanofi Pasteur
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • ALK-Abello A/S
  • Bavarian Nordic A/S
  • Crucell (Subsidiary of Johnson & Johnson)
  • CSL Limited
  • AstraZeneca PLC
  • Altimmune, Inc.
  • Abbott Laboratories
  • Hoffmann-La Roche, Inc.

Key Questions Answered in This Report:

  • 1. What was the global travel vaccines market size in 2020?
  • 2. What will be the travel vaccines market outlook during the forecast period (2021-2026)?
  • 3. What are the global travel vaccines market drivers?
  • 4. What are the major trends in the global travel vaccines market?
  • 5. What is the impact of COVID-19 on the global travel vaccines market?
  • 6. What is the global travel vaccines market breakup by composition?
  • 7. What is the global travel vaccines market breakup by disease?
  • 8. What are the major regions in the global travel vaccines market?
  • 9. Who are the leading travel vaccines market players?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Travel Vaccines Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Composition
  • 5.5 Market Breakup by Disease
  • 5.6 Market Breakup by Region
  • 5.7 Market Forecast

6 Market Breakup by Composition

  • 6.1 Mono Vaccines
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Combination Vaccines
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Disease

  • 7.1 Hepatitis A
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 DPT
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Yellow Fever
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Typhoid
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Hepatitis B
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Measles and Mumps
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast
  • 7.7 Rabies
    • 7.7.1 Market Trends
    • 7.7.2 Market Forecast
  • 7.8 Meningococcal
    • 7.8.1 Market Trends
    • 7.8.2 Market Forecast
  • 7.9 Varicella
    • 7.9.1 Market Trends
    • 7.9.2 Market Forecast
  • 7.10 Japanese Encephalitis
    • 7.10.1 Market Trends
    • 7.10.2 Market Forecast
  • 7.11 Others
    • 7.11.1 Market Trends
    • 7.12.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Europe
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Asia Pacific
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Middle East and Africa
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Latin America
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Global Travel Vaccines Industry: SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Global Travel Vaccines Industry: Value Chain Analysis

  • 10.1 Exploratory Stage
  • 10.2 Preclinical and Clinical Development
  • 10.3 Regulatory Approval
  • 10.4 Manufacturing
  • 10.5 Marketing and Distribution

11 Global Travel Vaccines Industry: Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Global Travel Vaccines Industry: Price Analysis

13 Travel Vaccines Manufacturing Process

  • 13.1 Product Overview
  • 13.2 Raw Material Requirements
  • 13.3 Manufacturing Process
  • 13.4 Key Success and Risk Factors

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 GlaxoSmithKline Pharmaceuticals Limited
    • 14.3.2 Sanofi Pasteur
    • 14.3.3 Merck & Co., Inc.
    • 14.3.4 Novartis AG
    • 14.3.5 Pfizer Inc.
    • 14.3.6 ALK-Abello A/S
    • 14.3.7 Bavarian Nordic A/S
    • 14.3.8 Crucell (Subsidiary of Johnson & Johnson)
    • 14.3.9 CSL Limited
    • 14.3.10 AstraZeneca PLC
    • 14.3.11 Altimmune, Inc.
    • 14.3.12 Abbott Laboratories
    • 14.3.13 Hoffmann-La Roche, Inc.
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.